Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Flu shots and the characteristics of unvaccinated elderly Medicare beneficiaries.

Authors:
Kimberly A Lochner Marc Wynne

Medicare Medicaid Res Rev 2011 Dec 21;1(4). Epub 2011 Dec 21.

US Department of Health and Human Services, Centers for Medicare & Medicaid Services, MD 21244, USA.

Key Findings: Data from the Medicare Current Beneficiary Survey, 2009. • Overall, 73% of Medicare beneficiaries aged 65 years and older reported receiving a flu shot for the 2008 flu season, but vaccination rates varied by socio-demographic characteristics. Flu vaccination was lowest for beneficiaries aged 65-74 years old, who were non-Hispanic Blacks and Hispanics, were not married, had less than a high school education, or who were eligible for Medicaid (i.e., dual eligibles). • Healthcare utilization and personal health behavior were also related to vaccination rates, with current smokers and those with no hospitalizations or physician visits being less likely to be vaccinated. • Among those beneficiaries who reported receiving a flu shot, 59% received it in a physician's office or clinic, with the next most common setting being in the community (21%); e.g., grocery store, shopping mall, library, or church. • Among those beneficiaries who did not receive a flu shot, the most common reasons were beliefs that the shot could cause side effects or disease (20%), that they didn't think the shot could prevent the flu (17%), or that the shot wasn't needed (16%). Less than 1% reported that they didn't get the flu shot because of cost. Elderly persons (aged 65 years and older) are at increased risk of complications from influenza, with the majority of influenza-related hospitalizations and deaths occurring among the elderly (Fiore et al., 2010). Most physicians recommend their elderly patients get a flu shot each year, and many hospitals inquire about elderly patient's immunization status upon admission, providing a vaccination if requested. The importance of getting a flu shot is underscored by the Department of Health and Human Services' Healthy People initiative, which has set a vaccination goal of 90% for the Nation's elderly by the year 2020 (Department of Health and Human Services [DHHS], 2011). Although all costs related to flu shots are covered by Medicare, requiring no co-pay on the part of the beneficiary (Centers for Medicare and Medicaid Services, 2011), for the 2008 flu season, only 73% of non-institutionalized Medicare beneficiaries, aged 65 years and older, reported receiving one. This report presents the most recent data on flu vaccination rates among non-institutionalized elderly Medicare beneficiaries and their association with socio-demographic and personal health characteristics. The report also describes the places beneficiaries received their flu shot and, for those not getting vaccinated, the reasons reported for not doing so.

Download full-text PDF

Source
http://dx.doi.org/10.5600/mmrr.001.04.b01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010448PMC
December 2011

Publication Analysis

Top Keywords

flu shot
28
medicare beneficiaries
16
flu
14
aged years
12
years older
12
reported receiving
12
beneficiaries aged
12
vaccination rates
12
shot
10
older reported
8
personal health
8
2008 flu
8
receiving flu
8
• beneficiaries
8
flu season
8
flu vaccination
8
beneficiaries
8
elderly medicare
8
department health
8
health human
8

Altmetric Statistics


Show full details
1 Total Shares
1 Tweets
1 Citations

Similar Publications

β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19.

Authors:
Nobunao Ikewaki Masaru Iwasaki Gene Kurosawa Kosagi-Sharaf Rao Johant Lakey-Beitia Senthilkumar Preethy Samuel Jk Abraham

Hum Vaccin Immunother 2021 Mar 2:1-6. Epub 2021 Mar 2.

The Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India.

Conventional vaccines to combat COVID-19 through different approaches are at various stages of development. The complexity of COVID-19 such as the potential mutations of the virus leading to antigenic drift and the uncertainty on the duration of the immunity induced by the vaccine have hampered the efforts to control the COVID-19 pandemic. Thus, we suggest an alternative interim treatment strategy based on biological response modifier glucans such as the AFO-202-derived β-glucan, which has been reported to induce trained immunity, akin to that induced by the Bacille Calmette-Guérin vaccine, by epigenetic modifications at the central level in the bone marrow. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Social Media Engagement and Influenza Vaccination: a Survey During the COVID-19 Pandemic.

Authors:
Arriel Benis Anna Khodos Sivan Ran Eugene Levner Shai Ashkenazi

J Med Internet Res 2021 Mar 1. Epub 2021 Mar 1.

Adelson School of Medicine, Ariel University, Ariel, IL.

Background: Vaccines are one of the most important achievements of modern medicine. However, their acceptance is only partial, with vaccine hesitancy and refusal representing a major health threat. Influenza vaccines have low compliance since repeated, annual vaccination is required. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Influenza vaccination: protecting the most vulnerable.

Authors:
Alex R Tanner Robert B Dorey Nathan J Brendish Tristan W Clark

Eur Respir Rev 2021 Mar 13;30(159). Epub 2021 Jan 13.

School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Influenza virus infection causes seasonal epidemics and occasional pandemics, leading to huge morbidity and mortality worldwide. Vaccination against influenza is needed annually as protection from constantly mutating strains is required. Groups at high risk of poor outcomes include the elderly, the very young, pregnant women and those with chronic health conditions. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Prospects of COVID-19 Vaccination in Romania: Challenges and Potential Solutions.

Authors:
Stefan Dascalu Oana Geambasu Ovidiu Covaciu Razvan Mircea Chereches Gabriel Diaconu Gindrovel Gheorghe Dumitra Valeriu Gheorghita Emilian Damian Popovici

Front Public Health 2021 10;9:644538. Epub 2021 Feb 10.

Department of Epidemiology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

The rapid advancement in vaccine development represents a critical milestone that will help humanity tackle the COVID-19 pandemic. However, the success of these efforts is not guaranteed, as it relies on the outcomes of national and international vaccination strategies. In this article, we highlight some of the challenges that Romania will face and propose a set of solutions to overcome them. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap